Antisense Therapeutics Limited Buy Hold or Sell Recommendation

ATHJFDelisted Stock  USD 0  0.00  0.00%   
Assuming the 90 days horizon and your bold attitude towards risk, our recommendation regarding Antisense Therapeutics Limited is 'Not Rated'. Macroaxis provides Antisense Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ATHJF positions.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
Note, we conduct extensive research on individual companies such as Antisense and provide practical buy, sell, or hold advice based on investors' constraints. Antisense Therapeutics Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

Execute Antisense Therapeutics Buy or Sell Advice

The Antisense recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Antisense Therapeutics Limited. Macroaxis does not own or have any residual interests in Antisense Therapeutics Limited or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Antisense Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Antisense TherapeuticsBuy Antisense Therapeutics
Not Rated
For the selected time horizon Antisense Therapeutics Limited has a Risk Adjusted Performance of (0.18), Jensen Alpha of (3.59), Total Risk Alpha of (5.64) and Treynor Ratio of 0.5121
We provide trade advice to complement the prevailing expert consensus on Antisense Therapeutics. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Antisense Therapeutics is not overpriced, please confirm all Antisense Therapeutics fundamentals, including its revenue, total debt, number of employees, as well as the relationship between the net income and book value per share . As Antisense Therapeutics appears to be a penny stock we also recommend to validate its price to earning numbers.

Antisense Therapeutics Trading Alerts and Improvement Suggestions

Antisense Therapeutics is not yet fully synchronised with the market data
Antisense Therapeutics generated a negative expected return over the last 90 days
Antisense Therapeutics has high historical volatility and very poor performance
Antisense Therapeutics has some characteristics of a very speculative penny stock
Antisense Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 1.78 M. Net Loss for the year was (5.81 M) with profit before overhead, payroll, taxes, and interest of 1.71 M.
Antisense Therapeutics Limited has accumulated about 19.23 M in cash with (7.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 19.0% of the company shares are held by company insiders

Antisense Therapeutics Returns Distribution Density

The distribution of Antisense Therapeutics' historical returns is an attempt to chart the uncertainty of Antisense Therapeutics' future price movements. The chart of the probability distribution of Antisense Therapeutics daily returns describes the distribution of returns around its average expected value. We use Antisense Therapeutics Limited price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Antisense Therapeutics returns is essential to provide solid investment advice for Antisense Therapeutics.
Mean Return
-4.13
Value At Risk
-79.05
Potential Upside
0.00
Standard Deviation
18.27
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Antisense Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Antisense Therapeutics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Antisense . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Antisense Therapeutics Buy or Sell Advice

When is the right time to buy or sell Antisense Therapeutics Limited? Buying financial instruments such as Antisense Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Antisense Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Target Risk ETFs Thematic Idea Now

Target Risk ETFs
Target Risk ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Risk ETFs theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Risk ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Consideration for investing in Antisense Pink Sheet

If you are still planning to invest in Antisense Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Antisense Therapeutics' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity